Neutralizing activity of Usnic acid and β-cyclodextrins complex against SARS-CoV-2 spike pseudovirus.

COVID-19 SARS-CoV-2 Usnic acid antiviral activity usnic acid and β-cyclodextrins complex

Journal

Natural product research
ISSN: 1478-6427
Titre abrégé: Nat Prod Res
Pays: England
ID NLM: 101167924

Informations de publication

Date de publication:
12 Jul 2023
Historique:
medline: 12 7 2023
pubmed: 12 7 2023
entrez: 12 7 2023
Statut: aheadofprint

Résumé

The rapid spread of SARS-CoV-2 and its infection severity require an urgent development of antiviral agents. In this respect, Usnic acid (UA), a natural dibenzofuran derivative, exerts antiviral activity against several viruses, though presenting very low solubility and high cytotoxicity. Here, UA was complexed with β-cyclodextrins (β-CDs), a pharmaceutical excipient used to improve drug solubility. The cytotoxic activity, tested on Vero E6 cells, revealed no effect for β-CDs alone whereas significant cytotoxicity for the UA/β-CDs complex was recorded at concentrations ≥ 0.05%. The neutralizing activity towards the fusion of SARS-CoV-2 Spike Pseudovirus showed no effects for β-CDs alone whereas the UA/β-CDs complex, when pre-incubated with the viral particles, efficiently inhibited the Pseudoviral fusion of about 90 and 82% at non-cytotoxic concentrations of 0.03 and 0.01%, respectively. In conclusion, although further evidences are needed to clarify the exact inhibition mechanism, UA/β-CDs complex could be useful in SARS-CoV-2 infection.

Identifiants

pubmed: 37436919
doi: 10.1080/14786419.2023.2235715
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-6

Auteurs

Luigi Rosa (L)

Department of Public Health and Infectious Diseases, University of Rome La Sapienza, Rome, Italy.

Antimo Cutone (A)

Department of Biosciences and Territory, University of Molise, Pesche, Italy.

Rebecca Galla (R)

Laboratory of Physiology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
Noivita srls, spin-off, Novara, Italy.

Francesca Uberti (F)

Laboratory of Physiology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.

Piera Valenti (P)

Department of Public Health and Infectious Diseases, University of Rome La Sapienza, Rome, Italy.

Classifications MeSH